Indegene Ltd Announces Board Meeting on April 29 to Approve FY26 Financial Results and Dividend
Indegene Ltd has announced that its Board of Directors meeting is scheduled for Wednesday, April 29, 2026. The meeting aims to approve several key financial results and operational matters pertaining to the year ended March 31, 2026.The board agenda includes the formal approval and recording of the company's financial performance for the quarter and the full year ended March 31, 2026.
Key items slated for approval during the board session include:
- Financial Results: Approval and record of the audited consolidated financial results of the Company and its subsidiaries, along with the Auditor's Report, as per Indian Accounting Standards (INDAS).
- Standalone Results: Approval and record of the audited standalone financial results of the Company, including the Auditor's Report, as per INDAS, for the quarter and year ended March 31, 2026.
- Dividend Recommendation: Recommendation of a final dividend for the year ended March 31, 2026. This dividend is subject to the final approval of the shareholders at the ensuing Annual General Meeting.
- Scheme Approvals: Approval for the allotment under the ESOP Scheme 2020 and the RSU Scheme 2020.
In relation to market trading, the company noted that the trading window for Indegene Ltd securities was closed on April 1, 2026. The window is set to reopen 48 hours after the declaration of the Audited Financial Results for the quarter and year ended March 31, 2026.
INDGN Stock Price Movement
Indegene Limited shares edged higher today, settling at ₹487.25, marking a solid 0.93% gain in after-hours trading. The stock’s upward momentum was sustained by a volume of 61,037 shares, closing well above its previous close of ₹482.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.